<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8">
<title>Comprehensive Overview of FRESCO Study: Efficacy, Safety, and Patient Demographics</title>
<style>

    body{
      margin: 0;
      font-family: Arial, sans-serif;
      background: #fff url('bg.png') no-repeat top center;
      background-size: cover;
      color: #002855;
      height: auto;
      display: flex;
      flex-direction: column;
      overflow: auto;
    }

    .txt-purple{
      color: #95429D;
    }

    .txt-bold{
      font-weight: bold;
    }

    .thelogo {
        width: 300px;
        margin-bottom: 25px;
    }

    header{
      position: relative;
      background:#95429D;
      padding: 15px 30px;
      color: #59CBE8;
      font-weight: bold;
      font-size: 20px;
      text-shadow: 1px 1px 3px rgba(0, 0, 0, 0.5);
      width: max-content;
      border-bottom-right-radius: 30px;
      overflow: auto;
    }

    .main {
        display: flex;
        padding: 20px 25px 10px 25px;
        flex: 1;
        gap: 10px;
        width: 1440px;
        margin: 0 auto;
        overflow: auto;
        box-sizing: border-box;
        min-height: auto;
        max-height: none;
    }
    .ai-content {
        flex: 65%;
        display: flex;
        flex-direction: column;
        overflow: auto;
    }
    .sidebar {
        flex: 35%;
        padding-left: 15px;
        padding-right: 20px;
    }

    .content-wrapper {
        display: flex;
        flex-direction: column;
        height: 100%;
        gap: 20px;
        overflow: auto;
    }

    .title-section {
        margin-bottom: 15px;
        flex-shrink: 0;
    }

    .main-title {
        color: #002855;
        font-size: 36px;
        font-weight: bold;
        margin: 0 0 15px 0;
        line-height: 1.2;
    }

    .subtitle {
        color: #95429D;
        font-size: 20px;
        font-weight: 600;
        margin: 0 0 20px 0;
        line-height: 1.3;
    }

    .statistics-text {
        display: flex;
        gap: 40px;
        margin-bottom: 20px;
        flex-shrink: 0;
    }

    .stat-text-item {
        flex: 1;
    }

    .stat-number {
        font-size: 48px;
        font-weight: bold;
        color: #002855;
        margin-bottom: 10px;
        line-height: 1;
    }

    .stat-description {
        font-size: 16px;
        font-weight: 600;
        color: #002855;
        line-height: 1.3;
    }

    .highlight-box {
        background: #95429D;
        color: white;
        padding: 20px 25px;
        border-radius: 10px;
        margin-bottom: 20px;
        flex-shrink: 0;
    }

    .highlight-title {
        font-size: 18px;
        font-weight: bold;
        margin: 0;
        line-height: 1.3;
    }

    .content-box {
        background: white;
        border-radius: 8px;
        padding: 25px;
        box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        flex: 1;
        overflow-y: auto;
    }

    .content-title {
        font-size: 18px;
        font-weight: bold;
        color: #002855;
        margin: 0 0 15px 0;
    }

    .content-text {
        font-size: 16px;
        line-height: 1.5;
        color: #333;
        margin-bottom: 20px;
    }

    .key-points {
        margin-top: 10px;
    }

    .point-item {
        display: flex;
        align-items: flex-start;
        margin-bottom: 12px;
        line-height: 1.4;
    }

    .point-item:last-child {
        margin-bottom: 0;
    }

    .bullet {
        color: #95429D;
        font-size: 16px;
        font-weight: bold;
        margin-right: 10px;
        flex-shrink: 0;
        margin-top: 2px;
    }

    .point-text {
        font-size: 15px;
        font-weight: 500;
        flex: 1;
        line-height: 1.4;
    }

    footer {
        display: grid;
        grid-template-columns: repeat(13, 1fr);
        gap: 1px;
        width: 100%;
        height: 60px;
        margin-top: auto;
    }
    footer .box {
        display: flex;
        align-items: center;
        justify-content: center;
        word-wrap: break-word;
        padding: 2px;
        text-align: center;
        font-size: 12px;
        font-weight: bold;
        color:#ffffff;
        cursor: pointer;
        position: relative;
        height: 60px;
        }
        .box.active::before,
        .box.active::after {
            content: "";
            position: absolute;
            top: 0;
            left: 50%;
            transform: translate(-50%, -50%);
            width: 0;
            height: 0;
        }
        .box.active::after {
            border-left: 10px solid transparent;
            border-right: 10px solid transparent;
            border-top: 10px solid #59CBE8;
            z-index: 2;
        }
        .box.active::before {
            border-left: 20px solid transparent;
            border-right: 20px solid transparent;
            border-top: 20px solid #ffffff;
            z-index: 1;
        }
    .homeicon {
        width: 40px;
    }
    .box.home {
        background: linear-gradient(to bottom, #632071, #500d5e);
    }
    .box.home:hover {
        background: linear-gradient(to bottom, #500d5e, #632071);
    }
    .box.purple {
        background: linear-gradient(to bottom, #6c2472, #95429D);
    }
    .box.purple:hover {
        background: linear-gradient(to bottom, #95429D, #6c2472);
    }
    .box.green{
        background: linear-gradient(to bottom, #81a13e, #a4c859);
    }
    .box.green:hover{
        background: linear-gradient(to bottom, #a4c859, #81a13e);
    }
    .box.blue{
        background: linear-gradient(to bottom, #3da1bb, #59CBE8);
    }
    .box.blue:hover{
        background: linear-gradient(to bottom, #59CBE8, #3da1bb);
    }
  
</style>
<style>

    body{
      margin: 0;
      font-family: Arial, sans-serif;
      background: #fff url('bg.png') no-repeat top center;
      background-size: cover;
      color: #002855;
      height: auto;
      display: flex;
      flex-direction: column;
      overflow: auto;
    }

    .txt-purple{
      color: #95429D;
    }

    .txt-bold{
      font-weight: bold;
    }

    .thelogo {
        width: 300px;
        margin-bottom: 25px;
    }

    header{
      position: relative;
      background:#95429D;
      padding: 15px 30px;
      color: #59CBE8;
      font-weight: bold;
      font-size: 20px;
      text-shadow: 1px 1px 3px rgba(0, 0, 0, 0.5);
      width: max-content;
      border-bottom-right-radius: 30px;
      overflow: auto;
    }

    .main {
        display: flex;
        padding: 20px 25px 10px 25px;
        flex: 1;
        gap: 10px;
        width: 1440px;
        margin: 0 auto;
        overflow: auto;
        box-sizing: border-box;
        min-height: auto;
        max-height: none;
    }
    .ai-content {
        flex: 65%;
        display: flex;
        flex-direction: column;
        overflow: auto;
    }
    .sidebar {
        flex: 35%;
        padding-left: 15px;
        padding-right: 20px;
    }

    /* Main Content Layout */
    .content-wrapper {
        display: flex;
        flex-direction: column;
        height: 100%;
        gap: 20px;
        overflow: auto;
    }

    /* Title Section */
    .title-section {
        margin-bottom: 15px;
        flex-shrink: 0;
    }

    .main-title {
        color: #002855;
        font-size: 36px;
        font-weight: bold;
        margin: 0 0 15px 0;
        line-height: 1.2;
    }

    .subtitle {
        color: #95429D;
        font-size: 20px;
        font-weight: 600;
        margin: 0 0 20px 0;
        line-height: 1.3;
    }

    /* Statistics Text Section */
    .statistics-text {
        display: flex;
        gap: 40px;
        margin-bottom: 20px;
        flex-shrink: 0;
    }

    .stat-text-item {
        flex: 1;
    }

    .stat-number {
        font-size: 48px;
        font-weight: bold;
        color: #002855;
        margin-bottom: 10px;
        line-height: 1;
    }

    .stat-description {
        font-size: 16px;
        font-weight: 600;
        color: #002855;
        line-height: 1.3;
    }

    /* Highlight Box */
    .highlight-box {
        background: #95429D;
        color: white;
        padding: 20px 25px;
        border-radius: 10px;
        margin-bottom: 20px;
        flex-shrink: 0;
    }

    .highlight-title {
        font-size: 18px;
        font-weight: bold;
        margin: 0;
        line-height: 1.3;
    }

    /* Content Box */
    .content-box {
        background: white;
        border-radius: 8px;
        padding: 25px;
        box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        flex: 1;
        overflow-y: auto;
    }

    .content-title {
        font-size: 18px;
        font-weight: bold;
        color: #002855;
        margin: 0 0 15px 0;
    }

    .content-text {
        font-size: 16px;
        line-height: 1.5;
        color: #333;
        margin-bottom: 20px;
    }

    .key-points {
        margin-top: 10px;
    }

    .point-item {
        display: flex;
        align-items: flex-start;
        margin-bottom: 12px;
        line-height: 1.4;
    }

    .point-item:last-child {
        margin-bottom: 0;
    }

    .bullet {
        color: #95429D;
        font-size: 16px;
        font-weight: bold;
        margin-right: 10px;
        flex-shrink: 0;
        margin-top: 2px;
    }

    .point-text {
        font-size: 15px;
        font-weight: 500;
        flex: 1;
        line-height: 1.4;
    }

    footer {
        display: grid;
        grid-template-columns: repeat(13, 1fr);
        gap: 1px;
        width: 100%;
        height: 60px;
        margin-top: auto;
    }
    footer .box {
        display: flex;
        align-items: center;
        justify-content: center;
        word-wrap: break-word;
        padding: 2px;
        text-align: center;
        font-size: 12px;
        font-weight: bold;
        color:#ffffff;
        cursor: pointer;
        position: relative;
        height: 60px;
        }
        .box.active::before,
        .box.active::after {
            content: "";
            position: absolute;
            top: 0;
            left: 50%;
            transform: translate(-50%, -50%);
            width: 0;
            height: 0;
        }
        .box.active::after {
            border-left: 10px solid transparent;
            border-right: 10px solid transparent;
            border-top: 10px solid #59CBE8;
            z-index: 2;
        }
        .box.active::before {
            border-left: 20px solid transparent;
            border-right: 20px solid transparent;
            border-top: 20px solid #ffffff;
            z-index: 1;
        }
    .homeicon {
        width: 40px;
    }
    .box.home {
        background: linear-gradient(to bottom, #632071, #500d5e);
    }
    .box.home:hover {
        background: linear-gradient(to bottom, #500d5e, #632071);
    }
    .box.purple {
        background: linear-gradient(to bottom, #6c2472, #95429D);
    }
    .box.purple:hover {
        background: linear-gradient(to bottom, #95429D, #6c2472);
    }
    .box.green{
        background: linear-gradient(to bottom, #81a13e, #a4c859);
    }
    .box.green:hover{
        background: linear-gradient(to bottom, #a4c859, #81a13e);
    }
    .box.blue{
        background: linear-gradient(to bottom, #3da1bb, #59CBE8);
    }
    .box.blue:hover{
        background: linear-gradient(to bottom, #59CBE8, #3da1bb);
    }
  
</style>
<style>

/* Enhanced HTML Merger: force page to be scrollable */
html, body {
    height: auto !important;
    overflow: auto !important;
}

/* Normalize fixed containers */
*[style*="overflow: hidden"] { 
    overflow: auto !important; 
}
*[style*="height: 100vh"] { 
    height: auto !important; 
}

/* Multi-page layout styles */
.merged-page-container {
    max-width: 1440px;
    margin: 0 auto;
    padding: 20px;
}

.merged-page-section {
    margin: 30px 0;
    padding: 20px 0;
}

.merged-page-section:not(:last-child) {
    border-bottom: 2px solid #e5e7eb;
    padding-bottom: 40px;
}

.merged-page-title {
    font-size: 24px;
    font-weight: bold;
    margin: 0 0 20px 0;
    padding: 15px 20px;
    background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
    color: white;
    border-radius: 8px;
    box-shadow: 0 2px 4px rgba(0,0,0,0.1);
}

.merged-page-content {
    position: relative;
}

/* Ensure main containers are not fixed height */
.main {
    height: auto !important;
    max-height: none !important;
    min-height: auto !important;
    overflow: visible !important;
}

</style>
</head>
<body>
<div class="merged-page-container">

                <div class="merged-page-section" id="page-1">
                    <div class="merged-page-content">
                        
<header>
    FRESCO Study
  </header>
<div class="main">
<div class="ai-content">
<div class="content-wrapper">
<div class="title-section">
<h1 class="main-title">Demographics and Baseline Characteristics</h1>
<h2 class="subtitle">Overview of the Patient Population in the FRESCO Study</h2>
</div>
<div class="statistics-text">
<div class="stat-text-item">
<div class="stat-number">416</div>
<div class="stat-description">Total Patients Enrolled</div>
</div>
<div class="stat-text-item">
<div class="stat-number">18%</div>
<div class="stat-description">Patients ≥ 65 years</div>
</div>
</div>
<div class="highlight-box">
<div class="highlight-title">Comprehensive analysis of patient demographics and key baseline characteristics provides insight into the study's population.</div>
</div>
<div class="content-box">
<div class="content-title">Key Findings</div>
<div class="content-text">The FRESCO study, a pivotal evaluation of fruquintinib in metastatic colorectal cancer, enrolled 416 patients. The cohort's demographics reveal valuable insights into the treatment's applicability and patient population.</div>
<div class="key-points">
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">The study included 416 patients with metastatic colorectal cancer.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Of these, 18% were 65 years of age or older, highlighting the relevance of elderly representation.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Efficacy and safety profiles of fruquintinib were consistent across age groups, with no significant differences observed in geriatric versus younger patients.</span>
</div>
</div>
</div>
</div>
</div>
<div class="sidebar">
<div id="p1-sidebar-logo">
<img class="thelogo" src="https://www.fruzaqlahcp.com/sites/default/files/2024-04/fruzaqla_logo_r_rgb.png"/>
</div>
<div id="p1-sidebar-text">
<h3 class="txt-purple">IMPORTANT SAFETY INFORMATION (continued) </h3>
<h4>WARNINGS AND PRECAUTIONS (continued)</h4>
<p>Impaired Wound Healing. In 911 patients with mCRC treated with FRUZAQLA, 1 patient experienced a Grade 2 event of wound dehiscence. Do not administer FRUZAQLA for at least 2 weeks prior to major surgery. Do not administer FRUZAQLA for at least 2 weeks after major surgery and until adequate wound healing. The safety of resumption of FRUZAQLA after resolution of wound healing complications has not been established.</p>
<p class="txt-bold">Please see additional Important Safety Information throughout, full <span class="txt-purple"><a href="">Important Safety Information</a></span>, and full <span class="txt-purple"><a href="">Prescribing Information</a></span> for FRUZAQLA. </p>
</div>
</div>
</div>
<footer>
<div class="box home">
<img class="homeicon" src="HomeIcon.png"/>
</div>
<div class="box purple">UNMET<br/>NEED/MOA</div>
<div class="box green">FRESCO-2</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box blue">FRESCO</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box purple">QOL/<br/>DOSING</div>
<div class="box purple">ASSIST/<br/>ISI</div>
<div class="box purple">ISI/<br/>REFERENCES</div>
</footer>
<script type="text/javascript">
    const boxes = document.querySelectorAll("footer .box");

    boxes.forEach(box => {
      box.addEventListener("click", () => {
        boxes.forEach(b => b.classList.remove("active"));
        box.classList.add("active");
      });
    });
  </script>

                    </div>
                </div>
                

                <div class="merged-page-section" id="page-2">
                    <div class="merged-page-content">
                        
<header>
    FRESCO Study
  </header>
<div class="main">
<div class="ai-content">
<div class="content-wrapper">
<!-- Title Section -->
<div class="title-section">
<h1 class="main-title">Efficacy Outcomes of Fruquintinib in mCRC</h1>
<h2 class="subtitle">Analysis of Overall Survival (OS) and Progression-Free Survival (PFS)</h2>
</div>
<!-- Statistics Text Section -->
<div class="statistics-text">
<div class="stat-text-item">
<div class="stat-number">9.3 months</div>
<div class="stat-description">Median Overall Survival (OS)</div>
</div>
<div class="stat-text-item">
<div class="stat-number">3.7 months</div>
<div class="stat-description">Median Progression-Free Survival (PFS)</div>
</div>
</div>
<!-- Highlight Box -->
<div class="highlight-box">
<div class="highlight-title">Fruquintinib Demonstrated Significant Efficacy</div>
</div>
<!-- Main Content Box -->
<div class="content-box">
<div class="content-title">Key Efficacy Findings</div>
<div class="content-text">The FRESCO study, a pivotal phase III trial, revealed important efficacy outcomes for fruquintinib in patients with metastatic colorectal cancer (mCRC). The analysis underscored the drug's potential in improving survival metrics over standard treatments.</div>
<!-- Key Points -->
<div class="key-points">
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Median OS was 9.3 months, reflecting a significant improvement over placebo.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Median PFS stood at 3.7 months, with clearer management of disease progression.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Overall survival benefits were consistent across various patient demographics.</span>
</div>
</div>
</div>
</div>
</div>
<div class="sidebar">
<div id="p2-sidebar-logo">
<img class="thelogo" src="https://www.fruzaqlahcp.com/sites/default/files/2024-04/fruzaqla_logo_r_rgb.png"/>
</div>
<div id="p2-sidebar-text">
<h3 class="txt-purple">IMPORTANT SAFETY INFORMATION (continued) </h3>
<h4>WARNINGS AND PRECAUTIONS (continued)</h4>
<p>Impaired Wound Healing. In 911 patients with mCRC treated with FRUZAQLA, 1 patient experienced a Grade 2 event of wound dehiscence. Do not administer FRUZAQLA for at least 2 weeks prior to major surgery. Do not administer FRUZAQLA for at least 2 weeks after major surgery and until adequate wound healing. The safety of resumption of FRUZAQLA after resolution of wound healing complications has not been established.</p>
<p class="txt-bold">Please see additional Important Safety Information throughout, full <span class="txt-purple"><a href="">Important Safety Information</a></span>, and full <span class="txt-purple"><a href="">Prescribing Information</a></span> for FRUZAQLA. </p>
</div>
</div>
</div><!--main-->
<footer>
<div class="box home">
<img class="homeicon" src="HomeIcon.png"/>
</div>
<div class="box purple">UNMET<br/>NEED/MOA</div>
<div class="box green">FRESCO-2</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box blue">FRESCO</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box purple">QOL/<br/>DOSING</div>
<div class="box purple">ASSIST/<br/>ISI</div>
<div class="box purple">ISI/<br/>REFERENCES</div>
</footer>
<script type="text/javascript">
    const boxes = document.querySelectorAll("footer .box");

    boxes.forEach(box => {
      box.addEventListener("click", () => {
        boxes.forEach(b => b.classList.remove("active"));
        box.classList.add("active");
      });
    });
  </script>

                    </div>
                </div>
                

                <div class="merged-page-section" id="page-3">
                    <div class="merged-page-content">
                        
<header>
    FRESCO Study
  </header>
<div class="main">
<div class="ai-content">
<div class="content-wrapper">
<!-- Title Section -->
<div class="title-section">
<h1 class="main-title">Safety Profile of Fruquintinib</h1>
<h2 class="subtitle">Analysis of Adverse Events in Metastatic Colorectal Cancer</h2>
</div>
<!-- Statistics Text Section -->
<div class="statistics-text">
<div class="stat-text-item">
<div class="stat-number">92.1%</div>
<div class="stat-description">Overall AE occurrence rate</div>
</div>
<div class="stat-text-item">
<div class="stat-number">27.6%</div>
<div class="stat-description">Grade 3 or 4 AE incidence</div>
</div>
</div>
<!-- Highlight Box -->
<div class="highlight-box">
<div class="highlight-title">Key Adverse Events Observed</div>
</div>
<!-- Main Content Box -->
<div class="content-box">
<div class="content-title">Detailed Findings on Safety</div>
<div class="content-text">In the FRESCO study, the safety profile of Fruquintinib was thoroughly assessed. The adverse events (AEs) associated with the treatment arose in 92.1% of patients. Significant AEs included hypertension, hand-foot skin reaction (HFSR), proteinuria, and hypothyroidism.</div>
<!-- Key Points -->
<div class="key-points">
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Hypotension affected 48.7% of patients, with 27.6% experiencing grade 3 or 4 events.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">HFSR was prevalent in 43.4% of participants, consistent with other trials.</span>
</div>
<div class="point-item">
<span class="bullet">•</span>
<span class="point-text">Proteinuria and hypothyroidism were observed in 27.6% and 22.4% of patients respectively.</span>
</div>
</div>
</div>
</div>
</div>
<div class="sidebar">
<div id="p3-sidebar-logo">
<img class="thelogo" src="https://www.fruzaqlahcp.com/sites/default/files/2024-04/fruzaqla_logo_r_rgb.png"/>
</div>
<div id="p3-sidebar-text">
<h3 class="txt-purple">IMPORTANT SAFETY INFORMATION (continued) </h3>
<h4>WARNINGS AND PRECAUTIONS (continued)</h4>
<p>Impaired Wound Healing. In 911 patients with mCRC treated with FRUZAQLA, 1 patient experienced a Grade 2 event of wound dehiscence. Do not administer FRUZAQLA for at least 2 weeks prior to major surgery. Do not administer FRUZAQLA for at least 2 weeks after major surgery and until adequate wound healing. The safety of resumption of FRUZAQLA after resolution of wound healing complications has not been established.</p>
<p class="txt-bold">Please see additional Important Safety Information throughout, full <span class="txt-purple"><a href="">Important Safety Information</a></span>, and full <span class="txt-purple"><a href="">Prescribing Information</a></span> for FRUZAQLA. </p>
</div>
</div>
</div><!--main-->
<footer>
<div class="box home">
<img class="homeicon" src="HomeIcon.png"/>
</div>
<div class="box purple">UNMET<br/>NEED/MOA</div>
<div class="box green">FRESCO-2</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box blue">FRESCO</div>
<div class="box purple">EFFICACY:<br/>OS</div>
<div class="box purple">EFFICACY:<br/>PFS</div>
<div class="box purple">SAFETY</div>
<div class="box purple">QOL/<br/>DOSING</div>
<div class="box purple">ASSIST/<br/>ISI</div>
<div class="box purple">ISI/<br/>REFERENCES</div>
</footer>
<script type="text/javascript">
    const boxes = document.querySelectorAll("footer .box");

    boxes.forEach(box => {
      box.addEventListener("click", () => {
        boxes.forEach(b => b.classList.remove("active"));
        box.classList.add("active");
      });
    });
  </script>

                    </div>
                </div>
                
</div>
</body>
</html>
